Compound DC-107 produced by Streptomyces sp.
US4999196A · kind A · utility
3Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 1989 |
| Grant date | Mar 12, 1991 |
| Priority date | — |
| Expiry date | Mar 29, 2009 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/886
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A novel compound, DC-107, is produced by culturing a microorganism belonging to the genus Streptomyces. It is useful as a medicine because of its antibacterial and anti-tumor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.